Skip to main content
Equibles

A. Rachel Leheny, Ph.D.

Board Member

CalciMedica, Inc. (CALC)

CEO

CalciMedica, Inc. (CALC)

Equibles does not estimate personal net worth.

Get an email with a short summary when CalciMedica, Inc. publishes a filing, an earnings call transcript or a press release.

Get CALC alerts

About A. Rachel Leheny, Ph.D.

A. Rachel Leheny, Ph.D. is recorded as Board Member at CalciMedica, Inc. (CALC) since June 24, 2025 and CEO at CalciMedica, Inc. (CALC) since March 22, 2023. CalciMedica, Inc. reported in an 8-K filed June 27, 2025 that A. Rachel Leheny, Ph.D. was appointed Class II director, effective June 24, 2025. CalciMedica, Inc. reported in an 8-K filed March 22, 2023 that A. Rachel Leheny, Ph.D. was appointed Chief Executive Officer. CalciMedica, Inc. reported in an 8-K filed March 22, 2023 that A. Rachel Leheny, Ph.D. was appointed Class II Director. Equibles holds 4 filed executive changes naming A. Rachel Leheny, Ph.D.; each is listed under recent activity with its source filing. CalciMedica, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CalciMedica, Inc. includes A. Rachel Leheny (CEO and Board Member), Ann Rachel Leheny (CEO), Ann Rachel Leheny, Ph.D. (CEO) and 7 others.

“The Company's stockholders elected the three persons listed below as Class II directors, each to serve a three-year term through the Company's 2028 annual meeting of stockholders and until a successor has been elected and qualified or until earlier resignation or removal.”
CalciMedica, Inc. Form 8-K, filed June 27, 2025 · Read the filing
“Dr. Leheny was appointed as the principal executive officer of the Company”
CalciMedica, Inc. Form 8-K, filed March 22, 2023 · Read the filing

Affiliation history

Company network

CalciMedica, Inc.

CALC

Current role

Biotechnology · Healthcare

Board Member, CEO

2023-03-22–present

Leadership on record at CalciMedica, Inc.

Recent activity